User profiles for "author:A Ravaggi"
Antonella RavaggiBiologo, Università degli Studi di Brescia Verified email at unibs.it Cited by 6466 |
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma
Uterine serous carcinoma (USC) is a biologically aggressive subtype of endometrial cancer.
We analyzed the mutational landscape of USC by whole-exome sequencing of 57 cancers …
We analyzed the mutational landscape of USC by whole-exome sequencing of 57 cancers …
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial–mesenchymal transition
…, S Wong, M Abu-Khalaf, A Ravaggi… - Proceedings of the …, 2016 - National Acad Sciences
Carcinosarcomas (CSs) of the uterus and ovary are highly aggressive neoplasms containing
both carcinomatous and sarcomatous elements. We analyzed the mutational landscape of …
both carcinomatous and sarcomatous elements. We analyzed the mutational landscape of …
Interleukin-10 Increases Th1 Cytokine Production and Cytotoxic Potential in Human Papillomavirus-Specific CD8+ Cytotoxic T Lymphocytes
AD Santin, PL Hermonat, A Ravaggi, S Bellone… - Journal of …, 2000 - Am Soc Microbiol
Interleukin-10 (IL-10) is widely known as an immunosuppressive cytokine by virtue of its
ability to inhibit macrophage-dependent antigen presentation, T-cell proliferation, and Th1 …
ability to inhibit macrophage-dependent antigen presentation, T-cell proliferation, and Th1 …
[HTML][HTML] Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients
Background: To date, no good marker for screening or disease monitoring of endometrial
cancer (EC) is available. The aims of this study were to investigate HE4 gene, protein …
cancer (EC) is available. The aims of this study were to investigate HE4 gene, protein …
Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial
…, S Bellone, M Palmieri, A Zanolini, A Ravaggi… - Journal of …, 2008 - Am Soc Microbiol
The safety and immunogenicity of the human papillomavirus type 16 (HPV16) or HPV18
(HPV16/18) E7 antigen-pulsed mature dendritic cell (DC) vaccination were evaluated for …
(HPV16/18) E7 antigen-pulsed mature dendritic cell (DC) vaccination were evaluated for …
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management
…, E Sartori, AD Santin, S Pecorelli, A Ravaggi - … , biomarkers & prevention, 2011 - AACR
Background: The aim of this work was to analyze the diagnostic and prognostic value of
serum human epididymis protein 4 (HE4) and Risk for Ovarian Malignancy Algorithm …
serum human epididymis protein 4 (HE4) and Risk for Ovarian Malignancy Algorithm …
HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study
Objective This multicenter study aims to evaluate HE4, CA125 and risk of ovarian
malignancy algorithm (ROMA) performance in the differential diagnosis of epithelial ovarian …
malignancy algorithm (ROMA) performance in the differential diagnosis of epithelial ovarian …
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients
…, M Falchetti, M Ravanini, RA Tassi, A Ravaggi… - European journal of …, 2010 - Elsevier
BACKGROUND: Prognostic factors currently available are insufficient to predict the clinical
course of epithelial ovarian cancer (EOC). In a previous microarray study we identified the …
course of epithelial ovarian cancer (EOC). In a previous microarray study we identified the …
HE4 and epithelial ovarian cancer: comparison and clinical evaluation of two immunoassays and a combination algorithm
…, E Bandiera, L Zanotti, S Belloli, A Ravaggi… - Clinica Chimica …, 2011 - Elsevier
Background Two commercial immunoassays for HE4 have been compared and the
diagnostic accuracy of HE4, CA 125 and the combinatory ROMA algorithm for epithelial …
diagnostic accuracy of HE4, CA 125 and the combinatory ROMA algorithm for epithelial …
Secretion of vascular endothelial growth factor in ovarian cancer.
AD Santin, PL Hermonat, A Ravaggi… - European journal of …, 1999 - europepmc.org
Vascular endothelial growth factor (VEGF) is an important regulator of vascular endothelial
cell function during vasculogenesis and tumor growth and is believed to play a major role in …
cell function during vasculogenesis and tumor growth and is believed to play a major role in …